- Home
- ABCL vs CHI Comparison
ABCL vs CHI Comparison
Compare ABCL & CHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- CHI
- Stock Information
- Founded
- ABCL 2012
- CHI 2002
- Country
- ABCL Canada
- CHI United States
- Employees
- ABCL N/A
- CHI N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- CHI Investment Managers
- Sector
- ABCL Health Care
- CHI Finance
- Exchange
- ABCL Nasdaq
- CHI Nasdaq
- Market Cap
- ABCL 818.2M
- CHI 841.2M
- IPO Year
- ABCL 2020
- CHI N/A
- Fundamental
- Price
- ABCL $3.03
- CHI $11.04
- Analyst Decision
- ABCL Buy
- CHI
- Analyst Count
- ABCL 3
- CHI 0
- Target Price
- ABCL $8.00
- CHI N/A
- AVG Volume (30 Days)
- ABCL 3.9M
- CHI 186.2K
- Earning Date
- ABCL 02-27-2025
- CHI 01-01-0001
- Dividend Yield
- ABCL N/A
- CHI 9.90%
- EPS Growth
- ABCL N/A
- CHI N/A
- EPS
- ABCL N/A
- CHI N/A
- Revenue
- ABCL $32,962,000.00
- CHI N/A
- Revenue This Year
- ABCL N/A
- CHI N/A
- Revenue Next Year
- ABCL $37.26
- CHI N/A
- P/E Ratio
- ABCL N/A
- CHI N/A
- Revenue Growth
- ABCL N/A
- CHI N/A
- 52 Week Low
- ABCL $2.34
- CHI $9.70
- 52 Week High
- ABCL $5.26
- CHI $11.61
- Technical
- Relative Strength Index (RSI)
- ABCL 45.64
- CHI 30.58
- Support Level
- ABCL $2.88
- CHI $11.03
- Resistance Level
- ABCL $3.60
- CHI $11.30
- Average True Range (ATR)
- ABCL 0.20
- CHI 0.10
- MACD
- ABCL -0.01
- CHI -0.01
- Stochastic Oscillator
- ABCL 20.83
- CHI 19.15
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About CHI Calamos Convertible Opportunities and Income Fund
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND operates as a closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in convertible securities and high-yield securities.